8 март 2024 г. - Wegovy Approved by The FDA

Описание:

The FDA expands the approval of semaglutide (Wegovy) to include heart disease, making it the first weight-loss drug to be approved for reducing the risk of cardiovascular events in adults who have cardiovascular disease and are either obese or overweight.

Добавлено на ленту времени:

Дата: